LV10912B - An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof - Google Patents

An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof Download PDF

Info

Publication number
LV10912B
LV10912B LVP-95-90A LV950090A LV10912B LV 10912 B LV10912 B LV 10912B LV 950090 A LV950090 A LV 950090A LV 10912 B LV10912 B LV 10912B
Authority
LV
Latvia
Prior art keywords
acyclovir
water
salt
weight
emulsion
Prior art date
Application number
LVP-95-90A
Other languages
English (en)
Latvian (lv)
Other versions
LV10912A (lv
Inventor
Knud Erik Gebhard-Hansen
Soren Bols Pedersen
Karen Bjornsdottir
Bodil Gyllembourg Lissau
Borge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of LV10912A publication Critical patent/LV10912A/xx
Publication of LV10912B publication Critical patent/LV10912B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LVP-95-90A 1992-09-09 1995-04-07 An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof LV10912B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
PCT/DK1993/000288 WO1994005258A1 (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof

Publications (2)

Publication Number Publication Date
LV10912A LV10912A (lv) 1995-12-20
LV10912B true LV10912B (en) 1996-08-20

Family

ID=8101156

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-90A LV10912B (en) 1992-09-09 1995-04-07 An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof

Country Status (27)

Country Link
EP (1) EP0662819B1 (bg)
JP (1) JPH08501089A (bg)
AT (1) ATE137113T1 (bg)
AU (1) AU4945393A (bg)
BG (1) BG62032B1 (bg)
BR (1) BR9307024A (bg)
CA (1) CA2142493A1 (bg)
CZ (1) CZ284007B6 (bg)
DE (1) DE69302396T2 (bg)
DK (1) DK169121B1 (bg)
EE (1) EE03088B1 (bg)
ES (1) ES2086235T3 (bg)
FI (1) FI112777B (bg)
GR (1) GR3019984T3 (bg)
HR (1) HRP931160B1 (bg)
HU (1) HUT72606A (bg)
LT (1) LT3056B (bg)
LV (1) LV10912B (bg)
NO (1) NO308234B1 (bg)
PL (1) PL172663B1 (bg)
RO (1) RO113306B1 (bg)
RU (1) RU2128503C1 (bg)
SI (1) SI9300469A (bg)
SK (1) SK280119B6 (bg)
UA (1) UA41897C2 (bg)
WO (1) WO1994005258A1 (bg)
ZA (1) ZA936661B (bg)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
WO2005102282A1 (en) * 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US20050257718A1 (en) * 2004-05-22 2005-11-24 Engelhard Corporation Natural Pearl in Butylene Glycol
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
US20120142623A1 (en) * 2006-07-07 2012-06-07 Michael Lagunoff Compositions And Methods For Predicting Inhibitors Of Protein Targets
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
MX337166B (es) 2009-06-24 2016-02-15 Composicion topica que contiene ibuoprofeno.
CN103429247A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations

Also Published As

Publication number Publication date
DK111392D0 (da) 1992-09-09
ZA936661B (en) 1994-05-20
AU4945393A (en) 1994-03-29
NO308234B1 (no) 2000-08-21
HRP931160A2 (en) 1995-12-31
SI9300469A (en) 1994-03-31
LV10912A (lv) 1995-12-20
EP0662819A1 (en) 1995-07-19
DE69302396T2 (de) 1996-08-14
RU95110930A (ru) 1997-03-27
RU2128503C1 (ru) 1999-04-10
FI951086A0 (fi) 1995-03-08
WO1994005258A1 (en) 1994-03-17
CZ284007B6 (cs) 1998-07-15
LTIP959A (en) 1994-05-15
HU9500702D0 (en) 1995-04-28
PL307860A1 (en) 1995-06-26
BR9307024A (pt) 1999-06-29
FI951086A (fi) 1995-03-08
EP0662819B1 (en) 1996-04-24
PL172663B1 (pl) 1997-10-31
ES2086235T3 (es) 1996-06-16
NO950895L (no) 1995-03-08
UA41897C2 (uk) 2001-10-15
HUT72606A (en) 1996-05-28
CZ59995A3 (en) 1995-09-13
DK111392A (da) 1994-03-10
DE69302396D1 (de) 1996-05-30
SK280119B6 (sk) 1999-08-06
EE03088B1 (et) 1998-06-15
JPH08501089A (ja) 1996-02-06
CA2142493A1 (en) 1994-03-17
SK29195A3 (en) 1997-01-08
LT3056B (en) 1994-10-25
RO113306B1 (ro) 1998-06-30
ATE137113T1 (de) 1996-05-15
BG99484A (bg) 1995-12-29
FI112777B (fi) 2004-01-15
DK169121B1 (da) 1994-08-22
HRP931160B1 (en) 1999-04-30
NO950895D0 (no) 1995-03-08
BG62032B1 (bg) 1999-01-29
GR3019984T3 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
US5314685A (en) Anhydrous formulations for administering lipophilic agents
LV10912B (en) An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof
EP0677126B1 (en) Antiviral topical pharmaceutical compositions
KR101517494B1 (ko) 디클로페낙의 신규한 비수용성 국소 용액 및 이를 제조하는 과정
Williams et al. Urea analogues in propylene glycol as penetration enhancers in human skin
CA2170016C (en) Improved method for treating hair loss
CA1179600A (en) Preparations for dermatoses
NO175406B (no) Fremgangsmåte ved fremstilling av piroxam i vandig opplösning
RU2733743C2 (ru) Терапевтическое применение лекарственных форм берберина
US20020055542A1 (en) Topical aromatic fatty acid composition
US5128135A (en) Percutaneous or trans-mucosal absorption enhancers, preparations containing the enhancers, and a method of preparing thereof
JP2570342B2 (ja) 外用液剤
JPH0383924A (ja) 経皮投与用組成物
US20220152061A1 (en) Compositions and methods for deep dermal drug delivery
WO1998057624A1 (de) Zur topischen applikation bestimmte diclofenac-lösung
ITMI972889A1 (it) Composizioni farmaceutiche per uso topico e/o transdermale